Cantor AB - Search Results

1

Prediction of radiation sensitivity using a gene expression classifier.

Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, McCarthy S, Cantor AB, Scuto A, Li C, Zhang S, Jove R, Yeatman T. Torres-Roca JF, et al. Among authors: cantor ab. Cancer Res. 2005 Aug 15;65(16):7169-76. doi: 10.1158/0008-5472.CAN-05-0656. Cancer Res. 2005. PMID: 16103067

2

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.

Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ. Agrawal D, et al. J Natl Cancer Inst. 2002 Apr 3;94(7):513-21. doi: 10.1093/jnci/94.7.513. J Natl Cancer Inst. 2002. PMID: 11929952

3

Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Blaskovich MA, et al. Cancer Res. 2003 Mar 15;63(6):1270-9. Cancer Res. 2003. PMID: 12649187

4

Molecular staging for survival prediction of colorectal cancer patients.

Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, Cantor A, Coppola D, Kruhøffer M, Aaltonen L, Orntoft TF, Quackenbush J, Yeatman TJ. Eschrich S, et al. J Clin Oncol. 2005 May 20;23(15):3526-35. doi: 10.1200/JCO.2005.00.695. J Clin Oncol. 2005. PMID: 15908663

5

Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Mora LB, et al. Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264

6

Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.

Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA. Diaz N, et al. Clin Cancer Res. 2006 Jan 1;12(1):20-8. doi: 10.1158/1078-0432.CCR-04-1749. Clin Cancer Res. 2006. PMID: 16397019

7

Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.

Torres-Roca JF, Cantor AB, Shukla S, Montejo ME, Friedland J, Seigne JD, Heysek R, Pow-Sang J. Torres-Roca JF, et al. Among authors: cantor ab. Urol Oncol. 2006 Sep-Oct;24(5):384-90. doi: 10.1016/j.urolonc.2005.12.003. Urol Oncol. 2006. PMID: 16962486

8

A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.

Heysek RV, Gwede CK, Torres-Roca J, Cantor A, Kelley S, Saini AS, Pow-Sang J. Heysek RV, et al. Brachytherapy. 2006 Oct-Dec;5(4):244-50. doi: 10.1016/j.brachy.2006.08.003. Brachytherapy. 2006. PMID: 17118318

9

Osteopontin identified as colon cancer tumor progression marker.

Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ. Agrawal D, et al. C R Biol. 2003 Oct-Nov;326(10-11):1041-3. doi: 10.1016/j.crvi.2003.09.007. C R Biol. 2003. PMID: 14744111 Free article.

10

Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment.

Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE. Yeatman TJ, et al. Among authors: cantor ab. Ann Surg Oncol. 1997 Apr-May;4(3):198-202. doi: 10.1007/BF02306610. Ann Surg Oncol. 1997. PMID: 9142379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters